Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

AIMS: To determine the effects of empagliflozin on blood pressure (BP) and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes mellitus (T2DM). METHODS: We conducted a post hoc analysis of data from a phase III trial in patients with T2DM and hypertension receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Chilton, R., Tikkanen, I., Cannon, C. P., Crowe, S., Woerle, H. J., Broedl, U. C., Johansen, O. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057299/
https://www.ncbi.nlm.nih.gov/pubmed/26343814
http://dx.doi.org/10.1111/dom.12572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057299/
https://www.ncbi.nlm.nih.gov/pubmed/26343814
http://dx.doi.org/10.1111/dom.12572

Ejemplares similares